tirzepatide august 22 2025 CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy Tirzepatide (Zepbound) for the Treatment
Description
Food and Drug Administration has approved semaglutide (Wegovy) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition
Semaglutide 1mg is a prescriber-directed weight-management medication option
Please call (347) 830-3003 and speak with Patient Coordinator, or fill out the form and we will contact you at your convenience
The time of weight loss ranged from 8 to 48 months (mean 20.07 months), and the duration of weight stability ranged from 6 to 24 months with mean 10.0 months
The reality star has always been vocal about her weight loss journey.
